TAK, US8740602052

Takeda Pharmaceutical stock trades at 52.50 times earnings

Published on 10/14/2026 at 17:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Value is JPY 9.4 trillion on October 14, 2026. Takeda Pharmaceutical stock costs EUR 16.90 on October 14, 2026, down 1.24 percent on TSE.

Valuation and market figures

On October 14, 2026, Takeda Pharmaceutical stock traded at a P/E ratio of 52.50.
The Tokyo listing was last at JPY 5,889 at 8:30 a.m. CEST on October 14, 2026.
Takeda Pharmaceutical stock costs EUR 16.90 at Lang & Schwarz on October 14, 2026 at 5:45 p.m. CEST, down 1.24 percent on the day on the Tokyo Stock Exchange.
Takeda Pharmaceutical had a market capitalization of JPY 9.4 trillion on October 14, 2026.

TAK, US8740602052, Illustration mit AI erstellt.

Takeda Pharmaceutical stock traded at a price-to-earnings ratio of 52.50 on October 14, 2026, placing valuation at the center of the market report. The Tokyo-listed line was last at JPY 5,889 at 8:30 a.m. CEST, down JPY 74, or 1.24 percent, from the previous close of JPY 5,963. At Lang & Schwarz, the stock was trading at EUR 16.90 after hours on October 14, 2026 at 5:45 p.m. CEST, down 1.24 percent on the day on the Tokyo Stock Exchange.

Valuation leads the comparison

Takeda's market capitalization stood at JPY 9.4 trillion on October 14, 2026. The P/E ratio of 52.50 was materially above the corresponding figures for the two Japanese pharmaceutical peers used in this market comparison, making earnings valuation the clearest point of separation.

The company profile places Takeda in the healthcare sector and specialty and generic drug manufacturing industry. Its portfolio spans gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience, giving the valuation multiple exposure to several treatment areas rather than one product category.

Tokyo trading sets the tone

The Tokyo price of JPY 5,889 remained inside the 52-week range of JPY 4,102 to JPY 6,033 on October 14, 2026. The session volume was 3,604,400 shares against an average volume of 4,172,233 shares, leaving current turnover below the reported average.

The euro quotation adds a separate perspective for German investors. EUR 16.90 at Lang & Schwarz is an after-hours indication, while the Tokyo session had already produced its dated JPY 5,889 price and minus 1.24 percent daily move.

Comparison with peers

Takeda Pharmaceutical (Tokyo Stock Exchange, JPY): minus 1.24 percent, P/E 52.50, market capitalization JPY 9.4 trillion

Astellas Pharma (Tokyo Stock Exchange, JPY): minus 1.65 percent, P/E 11.14, market capitalization JPY 4.1 trillion

Shionogi (Tokyo Stock Exchange, JPY): minus 0.87 percent, P/E 9.01, market capitalization JPY 2.4 trillion

Price for German investors

Takeda Pharmaceutical stock was trading at EUR 16.90 at Lang & Schwarz on October 14, 2026 at 5:45 p.m. CEST. The quoted bid was EUR 16.80 and the ask was EUR 17.00, keeping the spread at EUR 0.20 during after-hours trading.

The Tokyo listing was last at JPY 5,889 on October 14, 2026 at 8:30 a.m. CEST, while the home-market comparison showed a minus 1.24 percent move for the session. The figures place Takeda's valuation well above the selected peers even as all three pharmaceutical stocks moved lower in Tokyo.

The further course of trading is shown by the continuously updated real-time quote of Takeda Pharmaceutical stock.